clinical trial · NCT03235232
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
EMS·phase3·completed·n = 406
Ocular HypertensionPrimary Open-angle GlaucomaBREMEN eye dropsCombigan®
brief summary
The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the treatment of primary open-angle glaucoma or intraocular hypertension.
started
Feb 1, 2021
primary completion
Jul 31, 2023
completion
Oct 31, 2023
last updated
Feb 20, 2024
official title
Randomized Clinical Trial to Compare the Efficacy and Safety of BREMEN Eye Drops Versus Combigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol